Richard James
About Richard James
Richard James Co-founder
Richard James is the co-founder of Be Biopharma, an innovative biotechnology company established in October 2020. The company focuses on groundbreaking research in B cell engineering to develop new therapeutic solutions. Richard's role as a co-founder involves spearheading research initiatives and contributing to strategic planning for the company's growth and development.
Richard James Ph.D.
Richard James holds a Ph.D., adding a high level of academic expertise to his professional endeavors. His advanced education provides a strong foundation for his work in biotechnology, particularly in the specialization of B cell engineering. The knowledge and insights gained from his doctoral studies enhance his ability to drive forward impactful research and innovations at Be Biopharma.
Be Biopharma Co-founded by Richard James
In October 2020, Richard James co-founded Be Biopharma, a company dedicated to revolutionizing the field of B cell engineering. The establishment of Be Biopharma represents a significant milestone in Richard's career, marking his commitment to advancing biotherapeutics. The company aims to harness the power of B cells to develop new treatments and address unmet medical needs.
Richard James Seattle Children’s Research Institute
Before co-founding Be Biopharma, Richard James worked at Seattle Children's Research Institute. During his tenure, he was involved in leading-edge research that contributed to the field of biotechnology. His experience at the institute helped shape his expertise and prepared him for the challenges of his current role at Be Biopharma.
Richard James B Cell Engineering
Richard James specializes in B cell engineering, a field that focuses on modifying B cells to create new therapeutic strategies. His research in this area is central to Be Biopharma's mission. By leveraging his specialization, Richard aims to push the boundaries of current biotechnological applications, offering new hope for various medical conditions.